| |
| Magyar Diabetes Társaság |
|
| A gesztációs diabetes mellitus klinikai kérdései |
 Rendezvény kezdete: 2005.02.17. | Rendezvény vége: 2005.02.17. |
| Szervező: Dr. Bosnyák Zsolt |
| Munkahely neve: Szent Imre Kórház IV. Belosztálya |
| Címe: 1115 Budapest, Tétényi út 12-16. |
| Tel: 06-30-5453166 |
| E-mail: tamgyu@bel1.sote.hu |
| Helyszín: Szent Imre Kórház (1115 Budapest, Tétényi út 12-16., F épület, Tanácsterem) |
| A rendezvény Web oldala: http://www.oftex.hu |
A Diabétesz Gondozási Nemzeti Központ 2005. február 17-én ismét megrendezi gesztációs diabetes mellitus-szal foglalkozó egy napos továbbképző tanfolyamát.
A tanfolyam akkreditált, pontszerző, melyet a részvételi díj (8900Ft) befizetése után a tanfolyam végén tudunk igazolni. Befizetés számla ellenében a helyszínen. Részvétel a megjelölt részvételi díj befizetése nélkül is lehetséges, ebben az esetben azonban kredit pont igazolást nem tudunk kiállítani.
Jelentkezési határidő: 2005. január 31.
Mindenkit szeretettel várunk a tanfolyamra a Szent Imre Kórházban!
A részletes program elérhető a kapcsolódó dokumentumban. |
|
|
 |
| |
| A Csont-Ízületi Betegségek Korai Felismeréséért Alapítvány |
|
| Osteoporosis Akadémia |
| Rendezvény kezdete: 2005.02.18. | Rendezvény vége: 2005.02.18. |
| Szervező: Sidló Zsuzsa |
| Munkahely neve: MSD Magyarország Kft. |
| Címe: 1123 Budapest, Alkotás út 50. |
| Helyszín: Danubius Spa & Conference Hotel Visegrád, (2025 Visegrád-Lepencevölgy) |
péntek, 15.30
Tudományos program
Moderátorok: Lakatos Péter, Poór Gyula
15.30-16.00 Érkezés
16.00-16.10 Megnyitó
16.10-16.40
Paula Stern (USA): Cellular effects of bisphosphonates (szinkrontolmácsolással)
16.40-17.10
Clifford Rosen (USA): lace and role of bisphosphonates in osteoporosis treatment (szinkrontolmácsolással)
17.10-17.25
Lakatos Péter: Hosszútávú bizonyítékok a FOSAMAX-szal
17.25-17.45: Diszkusszió
17.45-19.45
A biszfoszfonátok egyéb hatásai
Téma:
- fájdalom (kazuisztika: Donáth Judit, összefoglaló: Bálint Géza)
- gyulladás (kazuisztika: Flórián Ágnes, összefoglaló: Szekeres László)
- prothesis-kilazulás (kazuisztika: Deli Anikó, összefoglaló: Somogyi Péter)
- ectopiás calcificatio és lipidszintek (kazuisztika: Koppány Viktória, összefoglaló (Speer Gábor)
- tumorok (kazuisztika: Mészáros Szilvia, összefoglaló: Nagy Zsolt)
- osteogenesis imperfecta (kazuisztika: Kiss Csaba, összefoglaló: Hosszú Éva)
20.15: Vacsora
|
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| IPC Current Knowledge and Future Directions in Psoriasis -1. Personalized medicine in psoriasis with a focus on stratification and biomarkers |
| Rendezvény kezdete: 2021.07.15. | Rendezvény vége: 2021.07.15. |
| Helyszín: online, |
| A rendezvény Web oldala: https://www.psoriasiscouncil.org/agenda_webinar1.htm |
Launching on July 15, 2021, "Current Knowledge and Future Directions in Psoriasis," is a five-part series of global webinars that will bring together IPC's cadre of experts from around the globe to cover essential topics in the field of psoriasis and provide an update on the current state of the disease, followed by presentations focusing on perspectives for the next five years.
The global webinar agendas are developed to provide practical information and to maximize interaction with the faculty. Through presentations and question and answer sessions, participants will obtain valuable information about psoriasis today and what we can expect in the future.
Webinar 1 | July 15, 2021
Personalized medicine in psoriasis with a focus on stratification and biomarkers
View the agenda and register for the first webinar of the series!
Thursday, July 15
9:30 — 10:30 am EDT
3:30 — 4:30 pm CEST
Agenda
WELCOME AND INTRODUCTION
Lars Iversen
Why we need to stratify in treatment of psoriasis
Lars Iversen
Biomarkers for practical use in 2021
Catherine Smith
Personalized treatment five years from now – perspectives from inflammatory bowel diseases
Claudio Fiocchi
Q & A and closing comments
Lars Iversen
ADJOURN |
|
|
|
